Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study (Q33391428)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
scientific article

    Statements

    Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study (English)
    Elena Lukina
    Elsa Avila Arreguin
    Marta Dragosky
    Marcelo Iastrebner
    Hanna Rosenbaum
    Mici Phillips
    Gregory M Pastores
    Ravi S Kamath
    Daniel I Rosenthal
    Mathilde Kaper
    Tejdip Singh
    Ana Cristina Puga
    M Judith Peterschmitt
    4095-4098

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit